Skip to main content
Clinical Trials/NL-OMON47353
NL-OMON47353
Completed
Not Applicable

Stromal Vascular Fraction injectable as a preventive treatment of scars. - SVF injectable as a treatment of scars.

niversitair Medisch Centrum Groningen0 sites40 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypertrophic skin
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
40
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Aged 18\-60
  • \- Mamma reduction in both mammae, wise pattern

Exclusion Criteria

  • \- Aged below 18 or above 60 years
  • \- Surgical interventions of the breasts in the year prior to the date of surgery
  • \- Mammareduction of 1 mamma
  • \- Any oncological event in the patients history
  • \- A known psychiatric condition
  • \- A known systemic disease that will impair wound healing (e.g. diabetes mellitus, known atherosclerosis with an event that required hospitalization, collagen diseases, diseases of the skin)
  • \- Prednisone or other immunotherapy
  • \- Pregnancy or active child wish
  • \- Frequent exposure to known carcinogenic substances (e.g. work related).
  • \- Active or previous use of hormone replacement therapy.

Outcomes

Primary Outcomes

Not specified

Similar Trials